logo

Stock Screener

Forex Screener

Crypto Screener

CME

CME Group Inc. (CME)

$

273.92

-0.78 (-0.28%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

11.4210

Market cap

Market cap

98.7 Billion

Price to sales ratio

Price to sales ratio

15.3188

Debt to equity

Debt to equity

0.1233

Current ratio

Current ratio

1.0186

Income quality

Income quality

1.1134

Average inventory

Average inventory

0

ROE

ROE

0.1372



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The company achieved a significant net income of $3,525,800,000.00 showcasing its strong financial health. The earnings per share (EPS) is reported at $9.69 indicating the company's profitability on a per-share basis. In terms of operational overhead, the company reported selling, general, and administrative expenses of $132,700,000.00 illustrating its cost management. The weighted average number of diluted shares outstanding is 359,944,000.00 reflecting potential dilution effects that investors may consider. Additionally, the company earned an interest income of $0.00 showcasing its financial investments that complement its core activities. CME Group offers a diverse array of futures and options products based on various financial instruments, serving a wide range of clientele including professional traders, institutions, and governments. Founded in 1898 and headquartered in Chicago, Illinois, it made its strategic name change from Chicago Mercantile Exchange Holdings Inc. to CME Group Inc. in July 2007. In terms of market performance, the stock is priced at $277.06 positioning it in the higher-end market. With a large market capitalization of $98,714,467,840.00 the company is a dominant player in the industry, specifically within the Financial - Data & Stock Exchanges sector, driving innovation and growth. The stock has a high average trading volume of 2,304,427.00 indicating strong liquidity that enhances investor participation. As a key player in the Financial - Data & Stock Exchanges industry, CME Group contributes significantly to the overall market landscape, leveraging its portfolio of products and services, including clearing house services, trade processing, and a wide range of market data services. By providing these essential services alongside its trading platforms, the company solidifies its role in the financial ecosystem, catering to a diverse clientele of corporations, manufacturers, investors, and central banks.

What is CME Group Inc. (CME)'s current stock price?

The current stock price of CME Group Inc. (CME) is $273.92 as of 2025-08-15. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in CME Group Inc. (CME) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict CME Group Inc. stock to fluctuate between $206.44 (low) and $290.79 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-15, CME Group Inc.'s market cap is $98,714,467,840, based on 360,377,000 outstanding shares.

Compared to JPMorgan Chase & Co., CME Group Inc. has a Lower Market-Cap, indicating a difference in performance.

CME Group Inc. pays dividends. The current dividend yield is 3.91%, with a payout of $1.25 per share.

To buy CME Group Inc. (CME) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CME. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

CME Group Inc.'s last stock split was 5:1 on 2012-07-23.

Revenue: $6,130,100,000 | EPS: $9.69 | Growth: 9.24%.

Visit https://www.cmegroup.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $290.79 (2025-06-02) | All-time low: $166.55 (2023-01-03).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CME

prnewswire.com

CME Group Interest Rate Futures Open Interest Sets New Record of 40 Million Contracts

Record U.S. Treasury futures and options OI of 31.6 million contracts Record SOFR futures OI of 13.7 million contracts CHICAGO , Aug. 14, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that open interest (OI) in its deeply liquid interest rate futures reached an all-time record of 40,031,688 contracts on August 13. The same day, CME Group U.S. Treasury futures and options OI hit a record 31,615,333 contracts and SOFR futures OI hit a record 13,738,220 contracts.

CME

seekingalpha.com

CME Group Q2: Elevated Average Daily Volume In July

I reiterate my Strong Buy rating on CME Group Inc. with a fair value of $319, driven by robust demand for risk hedging and record revenues. CME's ADV hit 21.9 million contracts in July, fueled by tariff uncertainties and volatile commodity prices, supporting sustained volume growth. Strategic expansion into the retail trading market is attracting new traders and diversifying revenue streams, enhancing long-term growth prospects.

CME

prnewswire.com

CME Group Declares Quarterly Dividend

CHICAGO , Aug. 7, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a third-quarter dividend of $1.25 per share. The dividend is payable September 25, 2025, to shareholders of record as of September 9, 2025.

CME

prnewswire.com

CME Group Reports Second-Highest July ADV of 21.9 Million Contracts

Record monthly ADV in cryptocurrency products CHICAGO , Aug. 4, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its second-highest July average daily volume (ADV) of 21.9 million contracts. The company set a July ADV record in 2024 with 24.8 million contracts.

CME

fool.com

CME Group Revenue Jumps 10% in Q2

CME Group (CME -0.41%), the major derivatives exchange operator known for its futures and options markets, reported financial results for the second quarter of 2025 on July 23, 2025. The company delivered record revenue of $1.7 billion, surpassing the consensus GAAP revenue estimate of $1.69 billion.

CME

wsj.com

CME Group Wins Lawsuit by Former Floor Traders

A jury rejects claims that the exchange operator broke its deal with traders when it shifted to electronic markets.

CME

seekingalpha.com

CME Group Inc. (CME) Q2 2025 Earnings Conference Call Transcript

CME Group Inc. (NASDAQ:CME ) Q2 2025 Earnings Call July 23, 2025 8:30 AM ET Company Participants Adam Minick - Investor Contact Terrence Duffy - Chairman & CEO Lynne Fitzpatrick - President & CFO Julie Winkler - Senior MD & Chief Commercial Officer Tim McCourt - Senior MD & Global Head of Equities, FX and Alternative Products Derek Sammann - Senior MD & Global Head of Commodities Markets Suzanne Sprague - Senior MD, Group COO & Global Head of Clearing Michael Dennis - Senior Managing Director & Global Head of Fixed Income Conference Call Participants Kwun Sum Lau - Oppenheimer & Co. Inc., Research Division Brian Bedell - Deutsche Bank AG, Research Division Christopher Allen - Citigroup Inc., Research Division Elias Abboud - BofA Securities, Research Division Daniel Fannon - Jefferies LLC, Research Division Alex Kramm - UBS Investment Bank, Research Division Kenneth Worthington - JPMorgan Chase & Co, Research Division Patrick Moley - Piper Sandler & Co., Research Division Michael Cyprys - Morgan Stanley, Research Division Kyle Voigt - Keefe, Bruyette, & Woods, Inc., Research Division Benjamin Budish - Barclays Bank PLC, Research Division Alexander Blostein - Goldman Sachs Group, Inc., Research Division Simon Alistair Clinch - Redburn (Europe) Limited, Research Division William Katz - TD Cowen, Research Division William Qi - RBC Capital Markets, Research Division Operator Welcome to the CME Group Second Quarter 2025 Earnings Call. [Operator Instructions] I would now like to turn the call over to Adam Minick.

CME

fool.com

CME Group Posts Record Q2 Revenue Up 10%

CME Group (CME 0.54%), the large U.S. derivatives and financial exchange operator, reported record-setting results for the quarter ended June 30, 2025. In its July 23, 2025, earnings release, the company announced revenue of $1.7 billion and adjusted earnings per share of $2.96.

CME

zacks.com

CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume

CME posts Q2 beats on earnings and revenue as record trading volume and rising fees lift results amid market volatility.

CME

zacks.com

Is a Beat in the Cards for CME Group This Earnings Season?

CME's second-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener